{
    "title": "Activist investor Elliott targets drugmaker BioMarin -sources",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12720799/Activist-investor-Elliott-targets-drugmaker-BioMarin-sources.html",
    "date": "2023-11-07",
    "keywords": [
        "company",
        "biomarin",
        "elliott",
        "drug",
        "biotechnology",
        "board",
        "stake",
        "hedge",
        "fund",
        "week",
        "price",
        "healthcare",
        "ceo",
        "bienaime",
        "york",
        "investor",
        "investment",
        "management",
        "future",
        "matter",
        "nature",
        "rafael",
        "palm",
        "beach",
        "florida",
        "representative",
        "request",
        "comment",
        "footing",
        "change",
        "progress",
        "launch",
        "roctavian",
        "guidance",
        "blockbuster",
        "status",
        "run",
        "yeartodate",
        "etf",
        "share",
        "fall",
        "takeover",
        "target",
        "portfolio",
        "veteran",
        "executive",
        "alexander",
        "genentech",
        "dec",
        "albeit",
        "place",
        "value",
        "seat",
        "meeting",
        "adviser",
        "end",
        "harvey",
        "richard",
        "meier",
        "director",
        "chairman",
        "catalent",
        "august",
        "syneos",
        "participating",
        "consortium",
        "year",
        "pharma",
        "allergan",
        "reporting",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}